Yuki serves as an associate at Mitsui Global Investment, and is currently focused on general technology investments(e.g. fintech, digital health, quantum computing). He serves as the board observer for Pica8 & has been involved in multiple investments at MGI(i.e. Rallybio, BioNova, Ensem Therapeutics).

Previously an investment manager at Mitsui & Co., he gained experience in structuring corporate insurance programs, trading commodity derivatives, and managing private equity fund investments.

Yuki received his Bachelor of Economics degree from The University of Tokyo. He is a  Certified Member Analyst of the Securities Analysts Association of Japan, and holds the Chartered Financial Analyst® designation.

In his free time, he likes to workout or to lose count of time playing boardgames such as Dominion, Catan or Poker.